57 related articles for article (PubMed ID: 7367251)
1. [Results of a survey of the risk factors involved in the incidence of female breast cancer (author's transl)].
Gest J; Brunet M; Guérit D
Nouv Presse Med; 1980 Mar; 9(14):1011-2. PubMed ID: 7367251
[TBL] [Abstract][Full Text] [Related]
2. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families.
Sellers TA; King RA; Cerhan JR; Chen PL; Grabrick DM; Kushi LH; Oetting WS; Vierkant RA; Vachon CM; Couch FJ; Therneau TM; Olson JE; Pankratz VS; Hartmann LC; Anderson VE
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1051-7. PubMed ID: 10613336
[TBL] [Abstract][Full Text] [Related]
3. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study.
Silvera SA; Miller AB; Rohan TE
Cancer Causes Control; 2005 Nov; 16(9):1059-63. PubMed ID: 16184471
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
[TBL] [Abstract][Full Text] [Related]
6. [Nutrition and carcinoma of the breast: presentation of a french investigation (author's transl)].
Lê M; Flamant R
Bull Cancer; 1978; 65(1):65-9. PubMed ID: 667373
[TBL] [Abstract][Full Text] [Related]
7. It won't happen to me: lower perception of heart disease risk among women with family histories of breast cancer.
Erblich J; Bovbjerg DH; Norman C; Valdimarsdottir HB; Montgomery GH
Prev Med; 2000 Dec; 31(6):714-21. PubMed ID: 11133339
[TBL] [Abstract][Full Text] [Related]
8. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
Bonadona V; Sinilnikova OM; Chopin S; Antoniou AC; Mignotte H; Mathevet P; Brémond A; Martin A; Bobin JY; Romestaing P; Raudrant D; Rudigoz RC; Léoné M; Chauvin F; Easton DF; Lenoir GM; Lasset C
Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246
[TBL] [Abstract][Full Text] [Related]
9. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
[TBL] [Abstract][Full Text] [Related]
10. The familial risk of breast cancer in women with endometriosis from Yale series.
Matalliotakis IM; Cakmak H; Mahutte N; Goumenou AG; Koumantakis G; Arici A
Surg Oncol; 2008 Dec; 17(4):289-93. PubMed ID: 18456491
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
12. Cancer incidence in first-degree relatives of a population-based set of cases of early-onset breast cancer.
Rawal R; Bertelsen L; Olsen JH
Eur J Cancer; 2006 Nov; 42(17):3034-40. PubMed ID: 16996259
[TBL] [Abstract][Full Text] [Related]
13. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Lynch HT; Neuhausen SL; Ghadirian P; Isaacs C; Weber B; Kim-Sing C; Foulkes WD; Gershoni-Baruch R; Ainsworth P; Friedman E; Daly M; Garber JE; Karlan B; Olopade OI; Tung N; Saal HM; Eisen A; Osborne M; Olsson H; Gilchrist D; Sun P; Narod SA
Cancer Causes Control; 2005 Aug; 16(6):667-74. PubMed ID: 16049805
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of susceptibility to breast cancer.
Hulka BS
Prog Clin Biol Res; 1996; 395():159-74. PubMed ID: 8895988
[TBL] [Abstract][Full Text] [Related]
15. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C
Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
[TBL] [Abstract][Full Text] [Related]
16. Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions.
Anderson WF; Matsuno RK; Sherman ME; Lissowska J; Gail MH; Brinton LA; Yang XR; Peplonska B; Chen BE; Rosenberg PS; Chatterjee N; Szeszenia-Dabrowska N; Bardin-Mikolajczak A; Zatonski W; Devesa SS; García-Closas M
Cancer Causes Control; 2007 May; 18(4):439-47. PubMed ID: 17216325
[TBL] [Abstract][Full Text] [Related]
17. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
Jamin C; Bourg F; Legeai J; Senoussi S
Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk among Finnish cabin attendants: a nested case-control study.
Kojo K; Pukkala E; Auvinen A
Occup Environ Med; 2005 Jul; 62(7):488-93. PubMed ID: 15961626
[TBL] [Abstract][Full Text] [Related]
19. Familial risk of breast cancer in a French case-control study.
Andrieu N; Clavel F; Gairard B; Piana L; Brémond A; Lansac J; Flamant R; Renaud R
Cancer Detect Prev; 1994; 18(3):163-9. PubMed ID: 8076378
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
Vogel VG
Menopause; 2008; 15(4 Suppl):782-9. PubMed ID: 18596599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
